Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

(Image Credit: AdobeStock) Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to improve visual function for patients with dry age-related macular degeneration (AMD).1 This new technology, the MacuMira system, is a non-invasive treatment now…

The recipients of this year’s Visionary in Eye Care Resident Recognition Awards were revealed at the Ophthalmology Times and Optometry Times EyeCon® 2025 conference, held September 26 and 27 at the Margaritaville Hollywood Beach Resort, in Hollywood, Florida. The program…

(Image Credit: AdobeStock) STAAR and Broadwood Partners have recently pleaded their case in the proposed merger between STAAR and Alcon, issuing statements both for and against the move, respectively. This follows the expiration of the “window shop” period in the…

Photo of Anat Loewenstein, MD, who served as the 2025 EURETINA president The Ramin Tadayoni Award is an initiative by the EURETINA board and Oculis company to honor the late Professor Ramin Tadayoni and support promising retinal research. This year,…

A new epidemiology study published in the British Journal of Ophthalmology reported that the prevalence rates and severity of myopia have seen major increases between generations because of increased axial elongation in the children. The investigators, led by first author…

A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity was unaffected in American college football players,1 reported first study author Nicholas G. Murray, PhD, from the Department…

Photo of Daniela Bacherini at the 2025 EURETINA meeting Daniela Bacherini, MD, PhD, FEBO, from the University of Florence presented at the EURETINA 2025 meeting, focusing on ultra widefield peripheral OCT imaging of retinal degenerations. She explored how this advanced…
As Ophthalmology Times celebrates its 50th anniversary, we took the opportunity to ask a thought-provoking question to some of the field’s leading experts: “In a perfect world, if you could cure one eye disease or condition with the snap of…

Photo of Boris Stanzel, MD, at the 2025 EURETINA meeting Professor Boris Stanzel, MD, presented research on methotrexate’s use in PVR retinal detachment surgery at the 2025 EURETINA congress, which was held in Paris, France. The study of 20 patients…

(Image credit: AdobeStock/phonlamaiphoto) Canadian researchers recently reported significant increases in complications during cataract surgeries performed during the COVID-19 pandemic compared with the pre-pandemic period.1 First author Nathan Lee-Wing, BS, and MD candidate at the Max Rady College of Medicine, University…